DOI . ORG {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,479,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, google, scholar, pubmed, cas, cancer, integrin, cell, patients, αvβ, advanced, phase, antibody, human, study, tumors, angiogenesis, clin, etaracizumab, monoclonal, solid, expression, therapy, cheresh, melanoma, alphavbeta, proc, tumor, privacy, cookies, content, humanized, delbaldo, faivre, access, growth, endothelial, cells, beta, usa, oncology, analysis, publish, search, receptor, vera, sandrine, safety, doses, mgkg,

Topics {✒️}

month download article/chapter advanced solid tumors world health organization targeted antiangiogenic therapy open-label study evaluating vegf/vegf-receptor pathway saint-louis university hospital luz hammershaimb karen kaucic human alphavbeta3 integrin+dacarbazine human endothelial cells endothelial cell activation αvβ3 integrin receptor beaujon university hospital monoclonal antibody directed monoclonal antibody specific humanized monoclonal antibody full article pdf solid tumors vascular integrin αvβ3 privacy choices/manage cookies ovarian epithelial tumors human breast cancer related subjects /ii trials progression-related expression renal cell carcinoma doses ranging 1–6 mg/kg human melanoma tumorigenicity single test dose tryrosine phosphorylation events cell adhesion sandrine faivre prostate cancer progression article investigational european economic area antiangiogenic therapy stetler-stevenson wg dimensional dermal collagen felding-habermann dynamic flow conditions angiogenic blood vessels vitro affinity maturation conditions privacy policy monoclonal antibody study evaluating cixutumumab check access instant access beta3 integrin agents /beta-5 integrin distribution

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
         description:This study assessed the safety, immunogenicity, and pharmacokinetics of etaracizumab, a monoclonal antibody directed against the αvβ3 integrin, in patients with advanced malignancies. Four cohorts of four patients received escalating dose of etaracizumab as a 30-min intravenous infusion, first as a single test dose, followed-up 2–5 weeks later by weekly doses. Sixteen patients with advanced solid tumors received a total of 309 cycles of etaracizumab at doses ranging 1–6 mg/kg. The mean number of weekly infusions was 19 (ranging 5–53). Frequently reported adverse events were grades 1–2 asthenia (15 patients) and infusion reactions (9 patients). At 1 mg/kg, one patient experienced grade 3 chills with the first infusion. Other grade 3 toxicities included reversible hyponatremia, hypophosphatemia and hyponatremia in one patient each at 1, 4 and 6 mg/kg, respectively. No patient experienced treatment delay/discontinuation due to an adverse event. The half-life of etaracizumab ranged 49–180 h with a nonlinear increase in terminal half-life with increasing doses. There was no objective response but five patients experienced a stable disease of >6-month duration. Etaracizumab was well-tolerated at doses up to 6 mg/kg with no evidence of immunogenicity. The safety profile of etaracizumab warrants further exploration in ongoing phase I/II trials.
         datePublished:2007-09-18T00:00:00Z
         dateModified:2007-09-18T00:00:00Z
         pageStart:35
         pageEnd:43
         sameAs:https://doi.org/10.1007/s10637-007-9077-0
         keywords:
            Angiogenesis
            αvβ3 receptor
            Advanced solid tumors
            Endothelial cell adhesion
            Vitaxin
            MEDI-522
            Oncology
            Pharmacology/Toxicology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-007-9077-0/MediaObjects/10637_2007_9077_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-007-9077-0/MediaObjects/10637_2007_9077_Fig2_HTML.gif
         isPartOf:
            name:Investigational New Drugs
            issn:
               1573-0646
               0167-6997
            volumeNumber:26
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Catherine Delbaldo
               affiliation:
                     name:Beaujon University Hospital
                     address:
                        name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric Raymond
               affiliation:
                     name:Beaujon University Hospital
                     address:
                        name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karina Vera
               affiliation:
                     name:Beaujon University Hospital
                     address:
                        name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luz Hammershaimb
               affiliation:
                     name:MedImmune Oncology
                     address:
                        name:MedImmune Oncology, Gaithersburg, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karen Kaucic
               affiliation:
                     name:MedImmune Oncology
                     address:
                        name:MedImmune Oncology, Gaithersburg, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stéphanie Lozahic
               affiliation:
                     name:Beaujon University Hospital
                     address:
                        name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michel Marty
               affiliation:
                     name:Saint-Louis University Hospital
                     address:
                        name:Department of Medical Oncology, Saint-Louis University Hospital, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sandrine Faivre
               affiliation:
                     name:Beaujon University Hospital
                     address:
                        name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                        type:PostalAddress
                     type:Organization
                     name:Hôpital Beaujon
                     address:
                        name:Service Inter-Hospitalier de Cancérologie Bichat-Beaujon, Hôpital Beaujon, Clichy Cedex, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
      description:This study assessed the safety, immunogenicity, and pharmacokinetics of etaracizumab, a monoclonal antibody directed against the αvβ3 integrin, in patients with advanced malignancies. Four cohorts of four patients received escalating dose of etaracizumab as a 30-min intravenous infusion, first as a single test dose, followed-up 2–5 weeks later by weekly doses. Sixteen patients with advanced solid tumors received a total of 309 cycles of etaracizumab at doses ranging 1–6 mg/kg. The mean number of weekly infusions was 19 (ranging 5–53). Frequently reported adverse events were grades 1–2 asthenia (15 patients) and infusion reactions (9 patients). At 1 mg/kg, one patient experienced grade 3 chills with the first infusion. Other grade 3 toxicities included reversible hyponatremia, hypophosphatemia and hyponatremia in one patient each at 1, 4 and 6 mg/kg, respectively. No patient experienced treatment delay/discontinuation due to an adverse event. The half-life of etaracizumab ranged 49–180 h with a nonlinear increase in terminal half-life with increasing doses. There was no objective response but five patients experienced a stable disease of >6-month duration. Etaracizumab was well-tolerated at doses up to 6 mg/kg with no evidence of immunogenicity. The safety profile of etaracizumab warrants further exploration in ongoing phase I/II trials.
      datePublished:2007-09-18T00:00:00Z
      dateModified:2007-09-18T00:00:00Z
      pageStart:35
      pageEnd:43
      sameAs:https://doi.org/10.1007/s10637-007-9077-0
      keywords:
         Angiogenesis
         αvβ3 receptor
         Advanced solid tumors
         Endothelial cell adhesion
         Vitaxin
         MEDI-522
         Oncology
         Pharmacology/Toxicology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-007-9077-0/MediaObjects/10637_2007_9077_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-007-9077-0/MediaObjects/10637_2007_9077_Fig2_HTML.gif
      isPartOf:
         name:Investigational New Drugs
         issn:
            1573-0646
            0167-6997
         volumeNumber:26
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Catherine Delbaldo
            affiliation:
                  name:Beaujon University Hospital
                  address:
                     name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric Raymond
            affiliation:
                  name:Beaujon University Hospital
                  address:
                     name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karina Vera
            affiliation:
                  name:Beaujon University Hospital
                  address:
                     name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luz Hammershaimb
            affiliation:
                  name:MedImmune Oncology
                  address:
                     name:MedImmune Oncology, Gaithersburg, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karen Kaucic
            affiliation:
                  name:MedImmune Oncology
                  address:
                     name:MedImmune Oncology, Gaithersburg, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stéphanie Lozahic
            affiliation:
                  name:Beaujon University Hospital
                  address:
                     name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michel Marty
            affiliation:
                  name:Saint-Louis University Hospital
                  address:
                     name:Department of Medical Oncology, Saint-Louis University Hospital, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sandrine Faivre
            affiliation:
                  name:Beaujon University Hospital
                  address:
                     name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
                     type:PostalAddress
                  type:Organization
                  name:Hôpital Beaujon
                  address:
                     name:Service Inter-Hospitalier de Cancérologie Bichat-Beaujon, Hôpital Beaujon, Clichy Cedex, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Investigational New Drugs
      issn:
         1573-0646
         0167-6997
      volumeNumber:26
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Beaujon University Hospital
      address:
         name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
         type:PostalAddress
      name:Beaujon University Hospital
      address:
         name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
         type:PostalAddress
      name:Beaujon University Hospital
      address:
         name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
         type:PostalAddress
      name:MedImmune Oncology
      address:
         name:MedImmune Oncology, Gaithersburg, USA
         type:PostalAddress
      name:MedImmune Oncology
      address:
         name:MedImmune Oncology, Gaithersburg, USA
         type:PostalAddress
      name:Beaujon University Hospital
      address:
         name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
         type:PostalAddress
      name:Saint-Louis University Hospital
      address:
         name:Department of Medical Oncology, Saint-Louis University Hospital, Paris, France
         type:PostalAddress
      name:Beaujon University Hospital
      address:
         name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
         type:PostalAddress
      name:Hôpital Beaujon
      address:
         name:Service Inter-Hospitalier de Cancérologie Bichat-Beaujon, Hôpital Beaujon, Clichy Cedex, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Catherine Delbaldo
      affiliation:
            name:Beaujon University Hospital
            address:
               name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
               type:PostalAddress
            type:Organization
      name:Eric Raymond
      affiliation:
            name:Beaujon University Hospital
            address:
               name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
               type:PostalAddress
            type:Organization
      name:Karina Vera
      affiliation:
            name:Beaujon University Hospital
            address:
               name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
               type:PostalAddress
            type:Organization
      name:Luz Hammershaimb
      affiliation:
            name:MedImmune Oncology
            address:
               name:MedImmune Oncology, Gaithersburg, USA
               type:PostalAddress
            type:Organization
      name:Karen Kaucic
      affiliation:
            name:MedImmune Oncology
            address:
               name:MedImmune Oncology, Gaithersburg, USA
               type:PostalAddress
            type:Organization
      name:Stéphanie Lozahic
      affiliation:
            name:Beaujon University Hospital
            address:
               name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
               type:PostalAddress
            type:Organization
      name:Michel Marty
      affiliation:
            name:Saint-Louis University Hospital
            address:
               name:Department of Medical Oncology, Saint-Louis University Hospital, Paris, France
               type:PostalAddress
            type:Organization
      name:Sandrine Faivre
      affiliation:
            name:Beaujon University Hospital
            address:
               name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
               type:PostalAddress
            type:Organization
            name:Hôpital Beaujon
            address:
               name:Service Inter-Hospitalier de Cancérologie Bichat-Beaujon, Hôpital Beaujon, Clichy Cedex, France
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
      name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
      name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
      name:MedImmune Oncology, Gaithersburg, USA
      name:MedImmune Oncology, Gaithersburg, USA
      name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
      name:Department of Medical Oncology, Saint-Louis University Hospital, Paris, France
      name:Department of Medical Oncology, Beaujon University Hospital, Clichy, France
      name:Service Inter-Hospitalier de Cancérologie Bichat-Beaujon, Hôpital Beaujon, Clichy Cedex, France
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(199)

• What's the income generated by https://link.springer.com/privacystatement each month?
• Learn how profitable https://link.springer.com/article/10.1007/s10637-007-9077-0/#main is on a monthly basis
• How much profit does https://link.springer.com generate?
• What's https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s10637-007-9077-0's gross income?
• How much income is https://link.springer.com/article/10.1007/s10637-007-9077-0/#eds-c-header-nav earning monthly?
• How much does https://link.springer.com/journals/ earn?
• What's the total monthly financial gain of https://www.springernature.com/gp/authors?
• https://link.springernature.com/home/ income
• How much profit does https://link.springer.com/article/10.1007/s10637-007-9077-0/#eds-c-header-popup-search make?
• How much does https://order.springer.com/public/cart net monthly?
• What are the total earnings of https://link.springer.com/article/10.1007/s10637-007-9077-0/?
• Revenue of https://link.springer.com/article/10.1007/s10637-007-9077-0/journal/10637
• What's the revenue for https://link.springer.com/article/10.1007/s10637-007-9077-0/#citeas?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/journal/10637/aims-and-scope rake in every month?
• Discover the revenue of https://submission.nature.com/new-submission/10637/3
• How much income does https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Catherine-Delbaldo-Aff1 have?
• Income figures for https://link.springer.com/article/10.1007/s10637-007-9077-0/#Aff1
• How much money does https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Eric-Raymond-Aff1 make?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Karina-Vera-Aff1 pull in?
• What's the monthly money flow for https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Luz-Hammershaimb-Aff3?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/#Aff3 pull in monthly?
• Revenue of https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Karen-Kaucic-Aff3
• What is the earnings of https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-St_phanie-Lozahic-Aff1?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Michel-Marty-Aff2 make?
• How much profit does https://link.springer.com/article/10.1007/s10637-007-9077-0/#Aff2 generate?
• What's the income generated by https://link.springer.com/article/10.1007/s10637-007-9077-0/#auth-Sandrine-Faivre-Aff1-Aff4 each month?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/#Aff4 generate monthly?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/article/10.1007/s10637-007-9077-0/metrics make?
• Explore the financials of https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10637-007-9077-0
• What is the monthly revenue of https://link.springer.com/product/springer-plus?
• What's the monthly money flow for https://www.springernature.com/gp/librarians/licensing/agc/journals?
• https://link.springer.com/10.1007/s00280-016-3189-1?fromPaywallRec=true's revenue stream
• See how much https://link.springer.com/10.1007/s00280-018-3622-8?fromPaywallRec=true makes per month
• How much revenue does https://link.springer.com/10.1007/s00280-016-3041-7?fromPaywallRec=true bring in?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s10637-007-9077-0/subjects/antibody-fragment-therapy?
• How profitable is https://link.springer.com/article/10.1007/s10637-007-9077-0/subjects/antibody-therapy?
• Income figures for https://link.springer.com/article/10.1007/s10637-007-9077-0/subjects/biologics
• What's the monthly income of https://link.springer.com/article/10.1007/s10637-007-9077-0/subjects/pharmacokinetics?
• How much money does https://link.springer.com/article/10.1007/s10637-007-9077-0/subjects/phase-iii-trials make?
• How much revenue does https://link.springer.com/article/10.1007/s10637-007-9077-0/subjects/targeted-therapies bring in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11961506 rake in every month?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Angiogenesis%20and%20antiangiogenic%20therapy&journal=Curr%20Probl%20Cancer&volume=26&pages=1-60&publication_year=2002&author=Sledge%2CG&author=Miller%2CK produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1703045 gross monthly?
• How much profit is https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK3MXpvFWktA%3D%3D making per month?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Cancer%20metastasis%20and%20angiogenesis%3A%20an%20imbalance%20of%20positive%20and%20negative%20regulation&journal=Cell&doi=10.1016%2F0092-8674%2891%2990642-C&volume=64&pages=327-336&publication_year=1991&author=Liotta%2CLA&author=Steeg%2CPS&author=Stetler-Stevenson%2CWG
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1555235 making per month?
• https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK38XitFWmtrg%3D income
• How profitable is http://scholar.google.com/scholar_lookup?&title=Integrins%3A%20versatility%2C%20modulation%2C%20and%20signaling%20in%20cell%20adhesion&journal=Cell&doi=10.1016%2F0092-8674%2892%2990115-S&volume=69&pages=11-25&publication_year=1992&author=Hynes%2CRO?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7526955 make?
• Check the income stats for https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK2cXltlSlu7c%3D
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Integrin%20mediated%20signal%20transduction%20in%20human%20endothelial%20cells%3A%20analysis%20of%20tryrosine%20phosphorylation%20events&journal=Cell%20Adhes%20Commun&doi=10.3109%2F15419069409014203&volume=2&pages=75-86&publication_year=1994&author=Defilippi%2CP&author=Bozzo%2CC&author=Volpe%2CG&author=Romano%2CG&author=Venturino%2CM&author=Silengo%2CL&author=Tarone%2CG
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14731415's revenue stream
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK2MXktFOisro%3D net monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Approaches%20to%20studying%20cell%20adhesion%20molecules%20in%20angiogenesis&journal=Trends%20Cell%20Biol&doi=10.1016%2FS0962-8924%2800%2988949-7&volume=5&pages=69-73&publication_year=1995&author=Bischoff%2CJ gross monthly?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1985087?
• Get to know what's the income of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK3MXnslSqsg%3D%3D
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Integrins&journal=J%20Clin%20Invest&volume=87&pages=1-5&publication_year=1991&author=Ruoslahti%2CE?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7681432 make?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK3sXhvVyltrc%3D generate monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=Integrin%20beta%201-%20and%20beta%203-mediated%20endothelial%20cell%20migration%20is%20triggered%20through%20distinct%20signaling%20mechanisms&journal=J%20Cell%20Biol&doi=10.1083%2Fjcb.121.1.163&volume=121&pages=163-170&publication_year=1993&author=Leavesley%2CD&author=Schwartz%2CMA&author=Rosenfeld%2CM&author=Ceresh%2CDA make?
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16169468's earnings
• Learn about the earnings of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtV2gt7vO
• What's http://scholar.google.com/scholar_lookup?&title=Tensional%20homeostasis%20and%20the%20malignant%20phenotype&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.08.010&volume=8&pages=241-254&publication_year=2005&author=Paszek%2CMJ's gross income?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10371505
• Income figures for https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK1MXjs1Kls7o%3D
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Extracellular%20matrix%20proteins%20protect%20small%20cell%20lung%20cancer%20cells%20against%20apoptosis%3A%20a%20mechanism%20for%20small%20cell%20lung%20cancer%20growth%20and%20drug%20resistance%20in%20vivo&journal=Nat%20Med&doi=10.1038%2F9511&volume=5&pages=662-668&publication_year=1999&author=Sethi%2CT is on a monthly basis
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7512751 make?
• How much profit is https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK2cXjt1Sis7w%3D making per month?
• How much income does http://scholar.google.com/scholar_lookup?&title=Requirement%20of%20vascular%20integrin%20%CE%B1v%CE%B23%20for%20angiogenesis&journal=Science&doi=10.1126%2Fscience.7512751&volume=264&pages=569-571&publication_year=1994&author=Brooks%2CPC&author=Clark%2CRA&author=Cheresh%2CDA have?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1376331
• Find out how much https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK38XksVGlt7s%3D earns monthly
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Involvement%20of%20integrin%20alpha%20V%20gene%20expression%20in%20human%20melanoma%20tumorigenicity&journal=J%20Clin%20Invest&doi=10.1172%2FJCI115811&volume=89&issue=6&pages=2018-2022&publication_year=1992&author=Felding-Habermann%2CB is on a monthly basis
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Progression-related%20expression%20of%20beta3%20integrin%20in%20melanomas%20and%20naevi&journal=Human%20Pathol&doi=10.1016%2FS0046-8177%2899%2990202-2&volume=30&issue=5&pages=562-567&publication_year=1999&author=Belle%2CPA?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10925366's revenue stream
• Learn about the earnings of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD3cXlvFahurs%3D
• See how much http://scholar.google.com/scholar_lookup?&title=In%20vivo%20therapy%20of%20malignant%20melanoma%20by%20means%20of%20antagonists%20of%20%CE%B1V%20integrins&journal=Int%20J%20Cancer&doi=10.1002%2F1097-0215%2820000901%2987%3A5%3C716%3A%3AAID-IJC14%3E3.0.CO%3B2-R&volume=87&pages=716-732&publication_year=2000&author=Mitjans%2CF&author=Meyer%2CT&author=Fittschen%2CC&author=Goodman%2CS&author=Jonczyk%2CA&author=Marshall%2CJF&author=Reyes%2CG&author=Piulats%2CJ makes per month
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10864205?
• https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD3cXksVChsLo%3D's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=Tissue%20factor%2C%20osteopontin%2C%20alphavbeta3%20integrin%20expression%20in%20microvasculature%20of%20gliomas%20associated%20with%20vascular%20endothelial%20growth%20factor%20expression&journal=Br%20J%20Cancer&doi=10.1054%2Fbjoc.2000.1150&volume=82&issue=12&pages=1967-1973&publication_year=2000&author=Takano%2CS generate monthly?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10894366?
• What's https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:STN:280:DC%2BD3M%2Fhs1OntQ%3D%3D's gross income?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Human%20malignant%20glioma%20therapy%20using%20anti-alpha%28v%29beta3%20integrin%20agents&journal=J%20Neurooncol&doi=10.1023%2FA%3A1006444300504&volume=46&issue=2&pages=135-144&publication_year=2000&author=Chatterjee%2CS?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7522323's revenue stream
• How much revenue does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK2cXmtVajtLg%3D produce monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Integrin%20%CE%B1v%CE%B23%20rescues%20melanoma%20cells%20from%20apoptosis%20in%20three-dimensional%20dermal%20collagen&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.91.19.8856&volume=91&pages=8856-8860&publication_year=1994&author=Montgomery%2CAMP&author=Reisfeld%2CRA&author=Cheresh%2CDA?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10363998?
• Find out how much https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK1MXjs1ymt70%3D earns monthly
• How much money does http://scholar.google.com/scholar_lookup?&title=Integrin%20%CE%B1v%CE%B23%20promotes%20M21%20melanoma%20growth%20in%20human%20skin%20by%20regulating%20tumor%20cell%20survival&journal=Cancer%20Res&volume=59&pages=2724-2730&publication_year=1999&author=Petitclerc%2CE make?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8886177?
• Monthly income for https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:STN:280:DyaK2s%2FktVyrtQ%3D%3D
• See how much http://scholar.google.com/scholar_lookup?&title=Alpha-V%2Fbeta-3%20and%20alpha-V%2Fbeta-5%20integrin%20distribution%20in%20neoplastic%20kidney&journal=Am%20J%20Nephrol&doi=10.1159%2F000169032&volume=16&pages=402-408&publication_year=1996&author=Rabb%2CH&author=Barroso-Vicens%2CE&author=Adams%2CR&author=Pow-Sang%2CJ&author=Ramirez%2CG makes per month
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10365138?
• What is the earnings of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:STN:280:DyaK1M3ptlCksA%3D%3D?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Renal%20cell%20carcinoma%3A%20immunohistological%20investigation%20of%20expression%20of%20the%20integrin%20alpha%20v%20beta%203&journal=Anticancer%20Res&volume=19&pages=1529-1532&publication_year=1999&author=Wechsel%2CHW&author=Petri%2CE&author=Feil%2CG&author=Nelde%2CHJ&author=Bichler%2CKH&author=Loesr%2CW is on a monthly basis
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11172040?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD3MXhsVWisLs%3D rake in every month?
• How much money does http://scholar.google.com/scholar_lookup?&title=Integrin%20activation%20controls%20metastasis%20in%20human%20breast%20cancer&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.98.4.1853&volume=98&issue=4&pages=1853-1858&publication_year=2001&author=Felding-Habermann%2CB generate?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20alpha%28v%29beta3%20integrin%20is%20less%20frequent%20in%20ovarian%20epithelial%20tumors%20of%20low%20malignant%20potential%20in%20contrast%20to%20ovarian%20carcinomas&journal=Human%20Pathol&doi=10.1016%2FS0046-8177%2897%2990033-2&volume=28&issue=4&pages=443-449&publication_year=1997&author=Liapsis%2CH?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Integrin%20alpha%20V%20beta%203%20expression%20by%20bone-residing%20breast%20cancer%20metastases&journal=Diagn%20Mol%20Pathol&doi=10.1097%2F00019606-199606000-00008&volume=5&issue=2&pages=127-135&publication_year=1996&author=Liapsis%2CH&author=Flath%2CA&author=Kitazawa%2CS
• Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11988838's earnings
• https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD38XksFGnu74%3D's financial summary
• How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20%CE%B1v%CE%B23%20in%20prostate%20cancer%20progression&journal=Neoplasia&doi=10.1038%2Fsj.neo.7900224&volume=4&pages=191-194&publication_year=2002&author=Cooper%2CCR&author=Chay%2CCH&author=Pienta%2CKJ produce monthly?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11934894?
• What's the monthly money flow for https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD38Xksl2jsb0%3D?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Unique%20ability%20of%20integrin%20%CE%B1v%CE%B23%20to%20support%20tumor%20cell%20arrest%20under%20dynamic%20flow%20conditions&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M201630200&volume=277&pages=21930-21938&publication_year=2002&author=Pilch%2CJ&author=Habermann%2CR&author=Felding-Habermann%2CB?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7513076
• How much revenue does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:STN:280:DyaK2c3hvVWhug%3D%3D bring in?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Immunohistological%20examination%20of%20the%20relationship%20between%20metastatic%20potential%20and%20expression%20of%20adhesion%20molecules%20and%20%E2%80%98selectins%E2%80%99%20on%20melanoma%20cells&journal=Pathology&doi=10.1080%2F00313029400169011&volume=26&pages=6-15&publication_year=1994&author=Si%2CZ&author=Hersey%2CP
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7528107?
• What is the earnings of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK2MXivVWqu7o%3D?
• Get to know http://scholar.google.com/scholar_lookup?&title=Integrin%20%CE%B1v%CE%B23%20antagonists%20promote%20tumor%20regression%20by%20inducing%20apoptosis%20of%20angiogenic%20blood%20vessels&journal=Cell&doi=10.1016%2F0092-8674%2894%2990007-8&volume=79&pages=1157-1164&publication_year=1994&author=Brooks%2CPC&author=Montgomery%2CAM&author=Rosenfeld%2CM&author=Reisfeld%2CRA&author=Hu%2CT&author=Klier%2CG&author=Cheresh%2CDA's earnings
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9585240?
• What's the profit of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK1cXjtFKgtr4%3D?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Detection%20of%20tumor%20angiogenesis%20in%20vivo%20by%20%CE%B1v%CE%B23-targeted%20magnetic%20resonance%20imaging&journal=Nat%20Med&doi=10.1038%2Fnm0598-623&volume=4&pages=623-626&publication_year=1998&author=Sipkins%2CDA&author=Cheresh%2CDA&author=Kazemi%2CMR&author=Nevin%2CLM&author=Bednarski%2CMD&author=Li%2CKC?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7560073 pull in?
• https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK2MXosFyhtr8%3D income
• http://scholar.google.com/scholar_lookup?&title=Anti-integrin%20%CE%B1v%CE%B23%20blocks%20human%20breast%20cancer%20growth%20and%20angiogenesis%20in%20human%20skin&journal=J%20Clin%20Invest&volume=96&pages=1815-1822&publication_year=1995&author=Brooks%2CPC&author=Stromblad%2CS&author=Klemke%2CR&author=Visscher%2CD&author=Sarkar%2CFH&author=Cheresh%2CDA's total income per month
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10955784?
• What's the financial intake of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD3cXmsVOmsbo%3D?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Targeted%20antiangiogenic%20therapy%20for%20cancer%20using%20vitaxin%3A%20a%20humanized%20monoclonal%20antibody%20to%20the%20integrin%20%CE%B1v%CE%B23&journal=Clin%20Cancer%20Res&volume=6&pages=3056-3061&publication_year=2000&author=Gutheil%2CJC&author=Campbell%2CTN&author=Pierce%2CPR&author=Watkins%2CJD&author=Huse%2CWD&author=Bodkin%2CDJ&author=Cheresh%2CDA making per month?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9600913 bring in each month?
• How much revenue does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DyaK1cXjtlKgsro%3D bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=Stepwise%20in%20vitro%20affinity%20maturation%20of%20vitaxin%2C%20an%20%CE%B1v%CE%B23%20specific%20humanized%20MAB&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.95.11.6037&volume=95&pages=6037-6042&publication_year=1998&author=Wu%2CHR&author=Beuerlein%2CG&author=Nie%2CY&author=Smith%2CH&author=Lee%2CBA&author=Hensler%2CM gross monthly?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17172415?
• What's the financial outcome of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD28XhtlagsbrF?
• How much does http://scholar.google.com/scholar_lookup?&title=Direct%20targeting%20of%20%CE%B1v%CE%B23%20integrin%20on%20tumor%20cells%20with%20a%20monoclonal%20antibody%2C%20Abegrin&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-06-0356&volume=5&pages=3122-3129&publication_year=2006&author=Mulgrew%2CK&author=Kineer%2CK&author=Yao%2CXT&author=Ward%2CBK&author=Damschroder%2CMM&author=Walsh%2CB&author=Mao%2CSY&author=Gao%2CC&author=Kiener%2CPA&author=Coats%2CS&author=Kinch%2CMS&author=Tice%2CDA earn?
• http://scholar.google.com/scholar_lookup?&title=WHO%20handbook%20for%20reporting%20results%20of%20cancer%20treatment%20%28offset%20publication%2048%29&publication_year=1979 income
• What's https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:STN:280:DC%2BD3c7it1Gitg%3D%3D's gross income?
• Revenue of http://scholar.google.com/scholar_lookup?&title=New%20guidelines%20to%20evaluate%20the%20response%20to%20treatment%20in%20solid%20tumors&journal=J%20Natl%20Can%20Inst&doi=10.1093%2Fjnci%2F92.3.205&volume=92&pages=205-216&publication_year=2000&author=Therasse%2CP&author=Arbuck%2CSG&author=Eisenhauer%2CEA&author=Wanders%2CJ&author=Kaplan%2CRS&author=Rubinstein%2CL
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12231573's gross income?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD38XntVKkurs%3D net monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20the%20coagulation%20cascade%20and%20endothelial%20cell%20activation%20during%20inhibition%20of%20the%20VEGF%2FVEGF-receptor%20pathway%20in%20cancer%20patients&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2F01.ATV.0000030186.66672.36&volume=22&pages=1500-1505&publication_year=2002&author=Kuenen%2CBC&author=Levi%2CM&author=Miejers%2CJC?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16314617 earns monthly
• What is the monthly revenue of https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD28Xot1ChtQ%3D%3D?
• http://scholar.google.com/scholar_lookup?&title=Safety%2C%20pharmacokinetic%2C%20and%20antitumor%20activity%20of%20SU11248%2C%20a%20novel%20oral%20multitarget%20tyrosine%20kinase%20inhibitor%2C%20in%20patients%20with%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.02.2194&volume=24&pages=25-35&publication_year=2006&author=Faivre%2CS&author=Delbaldo%2CC&author=Vera%2CK's financial summary
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=The%20safety%20of%20adding%20angiogenesis%20inhibition%20into%20treatment%20for%20colorectal%2C%20breast%2C%20and%20lung%20cancer%3A%20The%20Eastern%20Cooperative%20Oncology%20Group%E2%80%99s%20%28ECOG%29%20experience%20with%20bevacizumab%20%28anti-VEGF%29&journal=Proc%20Am%20Soc%20Clin%20Oncol&volume=22&publication_year=2003&author=Gray%2CR&author=Giantonio%2CBJ&author=O%E2%80%99Dwyer%2CPJ each month?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Bevacizumab%20%28anti-VEGF%29%20plus%20FOLFOX4%20in%20previously%20treated%20advanced%20colorectal%20cancer%20%28advCRC%29%3A%20An%20interim%20toxicity%20analysis%20of%20the%20Eastern%20Cooperative%20Oncology%20Group%20%28ECOG%29%20study%20E3200&journal=Proc%20Am%20Soc%20Clin%20Oncol&volume=22&publication_year=2003&author=Benson%2CAB&author=Catalano%2CPJ&author=Meropol%2CNJ
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11571751's financial summary
• Find out how much https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:STN:280:DC%2BD3Mritl2nsw%3D%3D earns monthly
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Pilot%20study%20of%20vitaxin%E2%80%94an%20angiogenesis%20inhibitor%E2%80%94in%20patients%20with%20advanced%20leiomyosarcomas&journal=Cancer&doi=10.1002%2F1097-0142%2820010901%2992%3A5%3C1347%3A%3AAID-CNCR1456%3E3.0.CO%3B2-0&volume=92&pages=1347-1348&publication_year=2001&author=Patel%2CSR&author=Jenkins%2CJ&author=Papadopoulous%2CN?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16278408?
• Find out how much https://link.springer.com/article/10.1007/s10637-007-9077-0/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtF2isL%2FJ earns monthly
• Find out how much http://scholar.google.com/scholar_lookup?&title=Phase%20I%20trial%20of%20a%20monoclonal%20antibody%20specific%20for%20alphavbeta3%20integrin%20%28MEDI-522%29%20in%20patients%20with%20advanced%20malignancies%2C%20including%20an%20assessment%20of%20effect%20on%20tumor%20perfusion&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-0262&volume=11&pages=7851-7860&publication_year=2005&author=McNeel%2CDG&author=Eickhoff%2CJ&author=Lee%2CFT earns monthly
• How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s10637-007-9077-0?format=refman&flavour=references bring in?
• Find out how much https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Catherine%20Delbaldo earns monthly
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Catherine%20Delbaldo
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Catherine%20Delbaldo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• See how much https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Eric%20Raymond makes per month
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eric%20Raymond making per month?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eric%20Raymond%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• How much revenue does https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Karina%20Vera bring in?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karina%20Vera earn?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karina%20Vera%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Luz%20Hammershaimb pull in monthly?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luz%20Hammershaimb's total income per month
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luz%20Hammershaimb%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• What's the income generated by https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Karen%20Kaucic each month?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karen%20Kaucic make?
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karen%20Kaucic%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Check the income stats for https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=St%C3%A9phanie%20Lozahic
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=St%C3%A9phanie%20Lozahic generate?
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22St%C3%A9phanie%20Lozahic%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• What's the financial intake of https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Michel%20Marty?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michel%20Marty?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michel%20Marty%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the monthly money flow for https://link.springer.com/article/10.1007/s10637-007-9077-0/search?sortBy=newestFirst&dc.creator=Sandrine%20Faivre?
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sandrine%20Faivre is on a monthly basis
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sandrine%20Faivre%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the financial outcome of https://link.springer.com/article/10.1007/s10637-007-9077-0/mailto:[email protected]?
• What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=Phase%20I%20and%20pharmacokinetic%20study%20of%20etaracizumab%20%28Abegrin%E2%84%A2%29%2C%20a%20humanized%20monoclonal%20antibody%20against%20%CE%B1v%CE%B23%20integrin%20receptor%2C%20in%20patients%20with%20advanced%20solid%20tumors&author=Catherine%20Delbaldo%20et%20al&contentID=10.1007%2Fs10637-007-9077-0©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=0167-6997&publicationDate=2007-09-18&publisherName=SpringerNature&orderBeanReset=true?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s10637-007-9077-0?format=refman&flavour=citation bring in each month?
• What's the total monthly financial gain of https://link.springer.com/article/10.1007/s10637-007-9077-0/search?query=Angiogenesis&facet-discipline="Medicine%20%26%20Public%20Health"?
• Profit of https://link.springer.com/article/10.1007/s10637-007-9077-0/search?query=%CE%B1%CE%B2%20receptor&facet-discipline="Medicine%20%26%20Public%20Health"
• Find out how much https://link.springer.com/article/10.1007/s10637-007-9077-0/search?query=Advanced%20solid%20tumors&facet-discipline="Medicine%20%26%20Public%20Health" earns monthly
• What's the profit of https://link.springer.com/article/10.1007/s10637-007-9077-0/search?query=Endothelial%20cell%20adhesion&facet-discipline="Medicine%20%26%20Public%20Health"?
• How much does https://link.springer.com/article/10.1007/s10637-007-9077-0/search?query=Vitaxin&facet-discipline="Medicine%20%26%20Public%20Health" make?
• What's the financial gain of https://link.springer.com/article/10.1007/s10637-007-9077-0/search?query=MEDI-522&facet-discipline="Medicine%20%26%20Public%20Health"?
• How much does https://link.springer.com/journals/a/1 bring in each month?
• Learn about the earnings of https://link.springer.com/books/a/1
• What are the earnings of https://link.springer.com/journals?
• How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral rake in every month?
• Income figures for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• What is the earnings of https://www.springernature.com/gp/products?
• What's the monthly income of https://www.springernature.com/gp/librarians?
• What's the total monthly financial gain of https://www.springernature.com/gp/societies?
• Monthly income for https://www.springernature.com/gp/partners
• Check the income stats for https://www.springer.com/
• How much revenue does https://www.nature.com/ bring in?
• What's the financial intake of https://www.biomedcentral.com/?
• Check the income stats for https://www.palgrave.com/
• Financial intake of https://www.apress.com/
• How much revenue does https://link.springer.com/brands/discover generate?
• How much revenue does https://www.springernature.com/gp/legal/ccpa bring in?
• How much does https://www.springernature.com/gp/info/accessibility rake in every month?
• How much revenue does https://link.springer.com/termsandconditions generate?
• Explore the financials of https://support.springernature.com/en/support/home
• How much money does https://link.springer.com/legal-notice generate?
• How much cash flow does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations have monthly?
• https://www.springernature.com/'s revenue stream

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mx.zoho.eu
• mx2.zoho.eu
• mx3.zoho.eu

Name Servers:

• josh.ns.cloudflare.com
• zita.ns.cloudflare.com

CDN Services {📦}

• Crossref